The non-invasive cardiac output monitoring device market is expected to reach US$ 3,30,902.81 thousand by 2027 from US$ 2,26,049.76 thousand in 2019; it is estimated to grow at a CAGR of 5.0% from 2020 to 2027. The measurement of cardiac output (CO) is essential in medical practice. In the past, invasive monitoring with a pulmonary artery catheter (PAC) was the gold standard used to measure CO, but in recent years, many minimally invasive or noninvasive devices have been developed to measure CO. Get sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00018134/?utm_source=FreePlatform&utm_medium=10183